NanoVibronix, Inc. (NAOV) financial statements (2021 and earlier)

Company profile

Business Address 525 EXECUTIVE BLVD
ELMSFORD, NY 10523
State of Incorp. DE
Fiscal Year End December 31
SIC 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 1,3388964,360106
Cash and cash equivalents 1,3388964,360106
Receivables 111144246
Inventory, net of allowances, customer advances and progress billings 1211447667
Inventory 1211447667
Prepaid expense 249424534
Other current assets 19   
Other undisclosed current assets  4118
Total current assets: 1,8381,2304,516221
Noncurrent Assets
Property, plant and equipment 48611
Prepaid expense   55
Other undisclosed noncurrent assets 194346338257
Total noncurrent assets: 198354349273
Other undisclosed assets  (4)  
TOTAL ASSETS: 2,0361,5804,865494
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 129 797565
Accounts payable 129 16882
Accrued liabilities   15099
Employee-related liabilities   219170
Taxes payable   260214
Other undisclosed current liabilities 280640  
Total current liabilities: 409640797565
Noncurrent Liabilities
Liabilities, other than long-term debt 279477434349
Accounts payable and accrued liabilities 279477434349
Other undisclosed noncurrent liabilities  640 2,079
Total noncurrent liabilities: 2791,1174342,428
Other undisclosed liabilities  (640)  
Total liabilities: 6881,1171,2312,993
Stockholders' equity
Stockholders' equity attributable to parent, including: 1,3484633,634(2,499)
Common stock 5442
Additional paid in capital 39,66932,99332,01020,073
Accumulated deficit (38,330)(32,563)(28,382)(22,576)
Other undisclosed stockholders' equity attributable to parent 42922
Total stockholders' equity: 1,3484633,634(2,499)
TOTAL LIABILITIES AND EQUITY: 2,0361,5804,865494

Income statement (P&L) ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues 530318239229
Revenue, net437 
Cost of revenue (249)(158)(88)(88)
Gross profit: 281160151141
Operating expenses (5,432)(4,463)(3,242)(2,457)
Operating loss: (5,151)(4,303)(3,091)(2,316)
Nonoperating income (expense) 102(22)(1,836)(398)
Investment income, nonoperating 102   
Other nonoperating expense  (22)(1,836)(398)
Interest and debt expense (303) (37) 
Loss from continuing operations before equity method investments, income taxes: (5,352)(4,325)(4,964)(2,714)
Other undisclosed income (loss) from continuing operations before income taxes (459)4437 
Loss from continuing operations before income taxes: (5,811)(4,281)(4,927)(2,714)
Income tax expense (benefit) 17127(38)(117)
Net loss attributable to parent: (5,794)(4,154)(4,965)(2,831)
Preferred stock dividends and other adjustments   (841) 
Net loss available to common stockholders, diluted: (5,794)(4,154)(5,806)(2,831)

Comprehensive Income ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss: (5,794)(4,154)(4,965)(2,831)
Comprehensive loss: (5,794)(4,154)(4,965)(2,831)
Other undisclosed comprehensive loss, net of tax, attributable to parent   (841) 
Comprehensive loss, net of tax, attributable to parent: (5,794)(4,154)(5,806)(2,831)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: